Turnstone Biologics (TSBX) Competitors $0.49 +0.03 (+6.41%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TSBX vs. DYAI, GANX, PASG, QTTB, RLYB, ICCC, CVM, ACHL, SCYX, and ATNMShould you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include Dyadic International (DYAI), Gain Therapeutics (GANX), Passage Bio (PASG), Q32 Bio (QTTB), Rallybio (RLYB), ImmuCell (ICCC), CEL-SCI (CVM), Achilles Therapeutics (ACHL), SCYNEXIS (SCYX), and Actinium Pharmaceuticals (ATNM). These companies are all part of the "pharmaceutical products" industry. Turnstone Biologics vs. Dyadic International Gain Therapeutics Passage Bio Q32 Bio Rallybio ImmuCell CEL-SCI Achilles Therapeutics SCYNEXIS Actinium Pharmaceuticals Dyadic International (NASDAQ:DYAI) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends. Does the media refer more to DYAI or TSBX? In the previous week, Dyadic International's average media sentiment score of 0.00 equaled Turnstone Biologics'average media sentiment score. Company Overall Sentiment Dyadic International Neutral Turnstone Biologics Neutral Which has more risk and volatility, DYAI or TSBX? Dyadic International has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 2.44, meaning that its stock price is 144% more volatile than the S&P 500. Does the MarketBeat Community prefer DYAI or TSBX? Dyadic International received 157 more outperform votes than Turnstone Biologics when rated by MarketBeat users. Likewise, 64.40% of users gave Dyadic International an outperform vote while only 50.00% of users gave Turnstone Biologics an outperform vote. CompanyUnderperformOutperformDyadic InternationalOutperform Votes16164.40% Underperform Votes8935.60% Turnstone BiologicsOutperform Votes450.00% Underperform Votes450.00% Which has preferable valuation and earnings, DYAI or TSBX? Dyadic International has higher earnings, but lower revenue than Turnstone Biologics. Dyadic International is trading at a lower price-to-earnings ratio than Turnstone Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDyadic International$3.36M15.39-$6.80M-$0.23-7.61Turnstone Biologics$19.31M0.59-$55.20M-$3.24-0.15 Do institutionals & insiders hold more shares of DYAI or TSBX? 28.0% of Dyadic International shares are held by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are held by institutional investors. 28.8% of Dyadic International shares are held by insiders. Comparatively, 32.1% of Turnstone Biologics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer DYAI or TSBX? Dyadic International currently has a consensus price target of $6.00, suggesting a potential upside of 242.86%. Turnstone Biologics has a consensus price target of $2.13, suggesting a potential upside of 332.70%. Given Turnstone Biologics' higher possible upside, analysts clearly believe Turnstone Biologics is more favorable than Dyadic International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dyadic International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Turnstone Biologics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is DYAI or TSBX more profitable? Turnstone Biologics has a net margin of 0.00% compared to Dyadic International's net margin of -188.09%. Turnstone Biologics' return on equity of -105.99% beat Dyadic International's return on equity.Company Net Margins Return on Equity Return on Assets Dyadic International-188.09% -149.16% -59.81% Turnstone Biologics N/A -105.99%-87.27% SummaryTurnstone Biologics beats Dyadic International on 8 of the 15 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSBX vs. The Competition Export to ExcelMetricTurnstone BiologicsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.36M$2.94B$5.14B$9.08BDividend YieldN/A1.90%5.09%4.23%P/E Ratio-0.1546.7390.0517.18Price / Sales0.59415.011,117.00116.99Price / CashN/A182.1042.9637.86Price / Book0.123.894.784.78Net Income-$55.20M-$42.21M$120.31M$225.60M7 Day Performance2.31%-2.15%-1.92%-1.23%1 Month Performance4.60%4.20%11.50%3.36%1 Year Performance-80.20%18.39%30.59%16.60% Turnstone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSBXTurnstone Biologics2.849 of 5 stars$0.49+6.4%$2.13+332.7%-79.7%$11.36M$19.31M-0.1582DYAIDyadic International1.6371 of 5 stars$1.49-8.6%$6.00+302.7%+12.2%$44.09M$3.36M-6.007Gap DownGANXGain Therapeutics2.4871 of 5 stars$1.65+1.4%$7.25+338.6%-36.1%$43.85M$50,000.00-1.4820PASGPassage Bio2.6866 of 5 stars$0.69-9.0%$7.75+1,022.4%-19.0%$42.65MN/A0.00130QTTBQ32 Bio2.8291 of 5 stars$3.50-5.4%$29.86+753.1%N/A$42.63M$-6,651,000.00-0.2439High Trading VolumeRLYBRallybio2.6948 of 5 stars$1.03-5.1%$9.75+851.2%-65.5%$42.53MN/A-0.6740ICCCImmuCellN/A$4.70-4.5%N/A-7.9%$41.89M$23.84M-9.8475Positive NewsGap DownCVMCEL-SCIN/A$0.65-5.8%N/A-73.0%$41.48MN/A-1.1943News CoverageGap DownACHLAchilles Therapeutics2.9925 of 5 stars$1.00+1.0%$4.00+300.0%+18.1%$41.10MN/A-0.60250SCYXSCYNEXIS0.8217 of 5 stars$1.08-5.3%N/A-46.0%$40.99M$8.57M-1.5460Gap DownATNMActinium Pharmaceuticals1.2441 of 5 stars$1.28+4.0%$7.40+478.7%N/A$39.89M$81,000.00-0.8849 Related Companies and Tools Related Companies Dyadic International Competitors Gain Therapeutics Competitors Passage Bio Competitors Q32 Bio Competitors Rallybio Competitors ImmuCell Competitors CEL-SCI Competitors Achilles Therapeutics Competitors SCYNEXIS Competitors Actinium Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TSBX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSBX Stock Alerts